deltatrials
Unknown PHASE3 NCT00113854

Mannitol as Adjunct Therapy for Childhood Cerebral Malaria

Effect of Mannitol as Adjunct Therapy on the Clinical Outcome of Childhood Cerebral Malaria in Mulago Hospital: A Randomised Clinical Trial

Sponsor: Makerere University

Conditions Cerebral Malaria
Interventions Mannitol
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Oct 31, 2004 Completion: May 31, 2005

A PHASE3 clinical study on Cerebral Malaria, this trial is ongoing. The trial is conducted by Makerere University and has accumulated 5 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Makerere University
Data source: Makerere University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Kampala, Uganda